Trailblazing Precision Oncology for Rare Tumor Subtypes

por Shee, Kevin, Miller, Todd W.
Publicado 2017

Immunotherapy for Head and Neck Cancer in the Era of Exponentially Increasing Health Care Expenditure

por Santana‐Davila, Rafael, Rodriguez, Cristina P.
Publicado 2017

The Power to Choose

por Greenfeld, Yeshayahu
Publicado 2018

Cognitive Computing to Guide Molecular‐Based Therapy Selection: Steps Forward amid Abundant Need

por Ellisen, Leif W.
Publicado 2018

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy

por Fanotto, Valentina, Uccello, Mario, Pecora, Irene, Rimassa, Lorenza, Leone, Francesco, Rosati, Gerardo, Santini, Daniele, Giampieri, Riccardo, Di Donato, Samantha, Tomasello, Gianluca, Silvestris, Nicola, Pietrantonio, Filippo, Battaglin, Francesca, Avallone, Antonio, Scartozzi, Mario, Lutrino, Eufemia Stefania, Melisi, Davide, Antonuzzo, Lorenzo, Pellegrino, Antonio, Ferrari, Laura, Bordonaro, Roberto, Vivaldi, Caterina, Gerratana, Lorenzo, Bozzarelli, Silvia, Filippi, Roberto, Bilancia, Domenico, Russano, Marco, Aprile, Giuseppe
Publicado 2018

Adolescents and Young Adults With a “Rare” Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors

por Stoneham, Sara J., Hale, Juliet P., Rodriguez‐Galindo, Carlos, Dang, Ha, Olson, Thomas, Murray, Matthew, Amatruda, James F., Thornton, Claire, Arul, G. Suren, Billmire, Deborah, Krailo, Mark, Stark, Dan, Covens, Al, Hurteau, Jean, Stenning, Sally, Nicholson, James C., Gershenson, David, Frazier, A. Lindsay
Publicado 2018

A Phase I Dose‐Escalation Study of Clofarabine in Patients with Relapsed or Refractory Low‐Grade or Intermediate‐Grade B‐Cell or T‐Cell Lymphoma

por Foss, Francine Marie, Parker, Terri
Publicado 2018

Two Doctors, One Patient, and a Common Goal

por Nabhan, Chadi, Topin, Jeremy
Publicado 2018

Chemoprevention in Patients with Peutz‐Jeghers Syndrome: Lessons Learned

por de Brabander, Justin, Eskens, Ferry A.L.M., Korsse, Susanne E., Dekker, Evelien, Dewint, Pieter, van Leerdam, Monique E., van Eeden, Susanne, Klümpen, Heinz‐Josef
Publicado 2018

Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan‐Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

por Edelman, Gerald, Rodon, Jordi, Lager, Joanne, Castell, Christelle, Jiang, Jason, Van Allen, Eliezer M., Wagle, Nikhil, Lindeman, Neal I., Sholl, Lynette M., Shapiro, Geoffrey I.
Publicado 2018

Early Steps in the Value of Cancer Care—Many Paths Remain Unexplored

por Goldstein, Daniel A., La Vecchia, Carlo, Goulart, Bernardo H.L.
Publicado 2018

Benefit‐Risk Summary of Regorafenib for the Treatment of Patients with Advanced Hepatocellular Carcinoma That Has Progressed on Sorafenib

por Pelosof, Lorraine, Lemery, Steven, Casak, Sandra, Jiang, Xiaoping, Rodriguez, Lisa, Pierre, Vadryn, Bi, Youwei, Liu, Jiang, Zirkelbach, Jeanne Fourie, Patel, Anuja, Goldberg, Kirsten B., McKee, Amy E., Keegan, Patricia, Pazdur, Richard
Publicado 2018

Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor

por Menegaz, Brian A., Cuglievan, Branko, Benson, Jalen, Camacho, Pamela, Lamhamedi‐Cherradi, Salah‐Eddine, Leung, Cheuk Hong, Warneke, Carla L., Huh, Winston, Subbiah, Vivek, Benjamin, Robert S., Patel, Shreyaskumar, Daw, Najat, Hayes‐Jordan, Andrea, Ludwig, Joseph A.
Publicado 2017

High‐Dose Mitotane‐Induced Encephalopathy in the Treatment of Adrenocortical Carcinoma

por Pape, Elise, Feliu, Catherine, Yéléhé‐Okouma, Mélissa, Colling, Natacha, Djerada, Zoubir, Gambier, Nicolas, Weryha, Georges, Scala‐Bertola, Julien
Publicado 2017

Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater

por Gulhati, Pat, Raghav, Kanwal, Shroff, Rachna, Varadhachary, Gauri, Javle, Milind, Qiao, Wei, Wang, Huamin, Morris, Jeffrey, Wolff, Robert, Overman, Michael J.
Publicado 2017

FDA Benefit‐Risk Assessment of Osimertinib for the Treatment of Metastatic Non‐Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation

por Odogwu, Lauretta, Mathieu, Luckson, Goldberg, Kirsten B., Blumenthal, Gideon M., Larkins, Erin, Fiero, Mallorie H., Rodriguez, Lisa, Bijwaard, Karen, Lee, Eunice Y., Philip, Reena, Fan, Ingrid, Donoghue, Martha, Keegan, Patricia, McKee, Amy, Pazdur, Richard
Publicado 2017

Anti‐EGFR Therapy in Small Bowel Adenocarcinoma

por Safyan, Rachael A., Neugut, Alfred I.
Publicado 2018

Does Chemotherapy Induce Metastases?

por Chabner, Bruce A.
Publicado 2018

EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma

por Tzogani, Kyriaki, van Hennik, Paula, Walsh, Ita, De Graeff, Pieter, Folin, Annika, Sjöberg, Jan, Salmonson, Tomas, Bergh, Jonas, Laane, Edward, Ludwig, Heinz, Gisselbrecht, Christian, Pignatti, Francesco
Publicado 2017

EMA Review of Daratumumab for the Treatment of Adult Patients with Multiple Myeloma

por Tzogani, Kyriaki, Penninga, Elisabeth, Schougaard Christiansen, Marie Louise, Hovgaard, Doris, Sarac, Sinan B., Camarero Jimenez, Jorge, Garcia, Isabel, Lafuente, Marta, Sancho‐López, Arantxa, Salmonson, Tomas, Gisselbrecht, Christian, Pignatti, Francesco
Publicado 2018